These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11900269

  • 1. Effects of tibolone on endogenous nitric oxide (nitrite/nitrate levels) in postmenopausal women.
    Akgül C, Canbaz M, Vural P.
    Int J Fertil Womens Med; 2002; 47(1):13-7. PubMed ID: 11900269
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide in postmenopausal women taking three different HRT regimens.
    Kesim MD, Aydin Y, Erdemir M, Atis A.
    Maturitas; 2005 Jan 10; 50(1):52-7. PubMed ID: 15590214
    [Abstract] [Full Text] [Related]

  • 3. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of menopause and tibolone on antioxidants in postmenopausal women.
    Vural P, Akgül C, Canbaz M.
    Ann Clin Biochem; 2005 May 15; 42(Pt 3):220-3. PubMed ID: 15949158
    [Abstract] [Full Text] [Related]

  • 10. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep 15; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 11. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
    Lundström E, Hirschberg AL, Söderqvist G.
    Maturitas; 2011 Dec 15; 70(4):361-4. PubMed ID: 21958943
    [Abstract] [Full Text] [Related]

  • 12. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
    Kiran H, Kiran G.
    Arch Gynecol Obstet; 2006 Apr 15; 274(1):9-12. PubMed ID: 16369811
    [Abstract] [Full Text] [Related]

  • 13. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK, Ahn JY, Jin DK, Yoon BK, Kim HS, Kim DS, Kang WC, Han SH, Choi IS, Shin EK.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1889-94. PubMed ID: 12933531
    [Abstract] [Full Text] [Related]

  • 14. Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study.
    Boyanov MA, Shinkov AD.
    Maturitas; 2005 Aug 16; 51(4):363-9. PubMed ID: 16039409
    [Abstract] [Full Text] [Related]

  • 15. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C, Keramopoulos D, Vourli G, Gaki V, Bredakis N, Keramopoulos A.
    Climacteric; 2005 Dec 16; 8(4):342-51. PubMed ID: 16390769
    [Abstract] [Full Text] [Related]

  • 16. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
    Bisanti T, Cavalieri AP, Capri O, Galoppi P, De Felice C, Porfiri LM, Perrone G.
    Minerva Ginecol; 2004 Apr 16; 56(2):125-30. PubMed ID: 15258540
    [Abstract] [Full Text] [Related]

  • 17. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.
    Menopause; 2006 Apr 16; 13(4):660-8. PubMed ID: 16837888
    [Abstract] [Full Text] [Related]

  • 18. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women.
    Cicinelli E, Ignarro LJ, Galantino P, Pinto V, Barba B, Schonauer S.
    Fertil Steril; 2002 Sep 16; 78(3):464-8. PubMed ID: 12215318
    [Abstract] [Full Text] [Related]

  • 19. Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers.
    Vural P, Canbaz M, Akgul C.
    Pharmacol Res; 2006 Apr 16; 53(4):367-71. PubMed ID: 16503406
    [Abstract] [Full Text] [Related]

  • 20. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
    Jamin C, Bourg F, Legeai J, Senoussi S.
    Gynecol Obstet Fertil; 2006 Mar 16; 34(3):224-32. PubMed ID: 16513401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.